These proteins induce the production of neutralizing antibodies during the course of an infection. As two antigens define the genotype, the genotypic designation has two components. The genotypic characteristic given by VP7 is specified as the G genotype since VP7 is a glycoprotein. Similarly, the genotypic characteristic given by VP4 is specified as the P genotype because this protein exhibits protease-sensitivity. Up to now, at least 19 G genotypes and 27 P genotypes have been described . Theoretically, many G/P combinations are possible within the binary system utilized to classify RV-A genotypes; however, the G1P[8], G2P [4] , G3P[8] , G4P[8] and G9P[8] combinations are the most commonly identified genotypes worldwide (Castello et al. 2004 , Gentsch et al. 2005 , Santos & Hoshino 2005a .
In addition to the G and P genotypes, the serology of VP6 is used to classify RV-A into subgroups (SG) I, II, I+II and non-I and non-II, which are defined according to the presence or absence of two distinct epitopes that are reactive with one, both or neither of the MAbs 255/60 and 631/9. The SG specificities are determined by amino acids located at positions 305, the region between amino acids positions 296 and 299 (SGI) and amino acid position 315 (SGII) (López et al. 1994 , Tang et al. 1997 . Many epidemiological studies have used subgrouping enzyme immunoassays (EIAs). Based upon these analyses, most human isolates fall into SGII (Arista et al. 1990 , Gómara et al. 2001 , while most animal isolates fall into SGI (Tang et al. 1997 ).
Diarrheal diseases remain a major public health concern, representing the second most important cause of child mortality in developing countries (Boschi-Pinto et al. 2008) . RV-A is one of the most prevalent pathogens associated with infantile gastroenteritis, being responsible, on a global scale, for nearly 611,000 deaths per year .
In Brazil, proportional mortality by acute diarrhea in children less than five years old presents significant variation by geographic region, as it is higher in the Northeastern and Northern regions (MS 2006) . These rates, on a national scale, present a decreasing trend over time. Between 1990 Between -2004 , for example, the proportional mortality associated with diarrheal diseases was reduced from 11% to 4% (MS 2006) (Fig. 1) .
It is difficult to estimate the proportion of infantile gastroenteritis associated-deaths that are caused by RV-A. An estimated rate of 40% has been reported; this rate varies according to the sanitation background. Barnes et al. (1998) reported a rate of RV-A infection of 39.6% among 3,785 hospitalized children with gastroenteritis between 1980-1993 in Australia. It has been demonstrated that the majority of RV-A gastroenteritis deaths occur in developing countries (Miller & McCann 2000) . In Brazil, gastroenteritis mortality data time series analysis indicated that deaths peak during winter, which suggests that RV-As play an important role in this context (Kale et al. 2004) . In line with these data, a recent analysis of WHO surveillance network data for 2001-2008 indicated that approximately 40% of diarrhea-related hospitalizations among children aged < 5 years worldwide are attributable to RV-A infection (CDC 2008) . Such a substantial worldwide burden of RV-A diarrhea indicates a significant potential health impact of vaccination. Other important viral pathogens causing acute diarrhea in children include noroviruses, astroviruses and enteric adenoviruses (Victoria et al. 2007a , b, Magalhães et al. 2007 , Andreasi et al. 2008 .
Longitudinal studies have shown that naturally acquired RV-A infections confer protection against subsequent severe RV-A diarrheic episodes (Bernstein et al. 1991 , Ward & Bernstein 1994 , Moulton et al. 1998 .
Asymptomatic infection of newborns has also been shown to reduce the likelihood of developing severe RV-A-gastroenteritis during childhood (Bishop et al. 1983 , Bhan et al. 1993 . Surveys carried out in Mexico show that protection increases with successive reinfections and that surveyed children did not develop RV-A gastroenteritis after two RV-A infections (Velazquez et al. 1996) . These findings encouraged the development of RV-A vaccines.
Transmission of most enteropathogens that are transmitted through the faecal/oral route can be interrupted by improving sanitation conditions and improving access to a safe water supply. RV-A gastroenteritis affects children in both developed and developing countries, which have distinct socioeconomic environments. For this reason, RV-A transmission cannot be mitigated by improvements in sanitation and improved access to a safe water supply. Therefore, an effective vaccine constitutes the only possible means of preventing transmission of RV-A diarrhea .
Several RV-A vaccine strategies have been attempted over the past two decades (Dennehy 2008 (Linhares et al. 2008 ), a phase III trial confirmed vaccine efficacy, in spite of a lower protection achieved against G2P[4] RV-A of 43.8%. Nevertheless, circulation of G2P[4] RV-A strains, which do not share the VP7 or VP4 surface antigen with the vaccine strain, was very low. This strain was detected in five vaccinated infants and in eight unvaccinated control recipients. A European Rotarix phase III trial was carried out in six countries (Czech Republic, Finland, France, Germany, Italy and Spain) (Vesikari et al. 2007 ). These studies demonstrated cross-protection against severe G2P[4] RV-A gastroenteritis (efficacy = 85.5%; 95% CI = 24-98.5) (Vesikari et al. 2007 ).
The objective of this review is to describe the distribution of RV-A genotypes in five Brazilian regions from 1982-2007. We aim to provide a general overview of the changing trends in the detection rates of distinct RV-A genotypes by reviewing data available for this period, stratified by geographic region. This analysis allows for a comparison of rates for the pre and early post-vaccination periods. A literature review on rotavirus serotyping and genotyping in Brazil identified 42 articles describing RV-A detection and typing of 2,691 stool samples collected from 1982-2007. Among these surveys, 16 (39%) were carried out in the Southeast (states of Rio de Janeiro, São Paulo, Minas Gerais and Espírito Santo), seven (17%) in the North (state of Pará), seven (17%) in the Northeast (states of Bahia, Maranhão, Sergipe, Pernambuco, and Piauí), five (12%) in the Central-West (states of Goiás and Mato Grosso do Sul) and one (3%) in the South (state of Paraná) of Brazil. One study (3%) was carried out in several regions (states of Pernambuco, Alagoas, Bahia, Minas Gerais, Rio de Janeiro, São Paulo, Goiás, Paraná and Santa Catarina) and Federal District throughout the country.
The pre-vaccination era was divided in two periods. The first period included 653 RV-A-positive samples that were collected from 1982-1995; these cases were reported in 15 papers in our literature review (Linhares et al. 1988 , Stewien et al. 1994 , Gusmão et al. 1995 , Leite et al. 1996 , Mascarenhas et al. 1998 , Cardoso et al. 2000 , 2001 , Carmona et al. 2004 . The second period included 1,839 RV-A-positive samples that were collected from 1996-2005; these cases were reported in 19 articles in our literature review (Santos et al. 1998 , 2005b , Araújo et al. 2002 , Rosa-e-Silva et al. 2002 , Souza et al. 2003 , Luz et al. 2005 , Carmona et al. 2006 , Carvalho-Costa et al. 2006 , 2009 , Pietruchinski et al. 2006 , Andreasi et al. 2007 , Gouvea et al. 2007 , Montenegro et al. 2007 , Martini et al. 2008 , Domingues et al. 2008 , Ribeiro et al. 2008 . Altogether, during the pre-vaccination era, 2,492 RV-A-positive faecal samples were typed, either by use of monoclonal antibody or PCR assays. Only one paper in our review describes genotyping of RV-A-positive samples collected from 1994-1996 (i.e., during both defined periods), without specifying the results by year; therefore, this article has been reviewed separately (Macedo et al. 2007 ). Finally, seven papers report 199 RV-A-positive samples that were collected after introduction of universal RV-A vaccination (2006 RV-A vaccination ( -2007 (Araújo et al. 2007a , Gouvea et al. 2007 , Gurgel et al. 2007 , Domingues et al. 2008 , Ribeiro et al. 2008 , CarvalhoCosta et al. 2009 ). From these, five papers included samples collected before 2006, which were categorized as belonging to the pre-vaccination era.
We opted not to include RV-A G5P [8] in the category of atypical genotypes, since it was frequently detected in stool samples collected in the 1980s and early 1990s in Brazil. The following genotypes were considered atypical: VP7 genotypes G6, G8, G10 and G12 and unusual
Our analysis excluded untyped and only VP4-typed samples. Fig. 2 presents the RV-A genotypes that were identified across geographic regions during the pre-vaccination era . Fig. 3 shows the nationwide detection rates of RV-A genotypes in the following three periods: 1982-1995, 1996-2005 and 2006-2007 Taken together, these findings underscore the broad diversity of RV-A genotypes in Brazil. The substitution of G5 by G9 RV-As from 1996 onwards motivated us to choose this year to separate two periods in the pre-vaccination era.
In reviewing the eight papers that describe the distribution of RV-A genotypes following introduction of RV-A vaccine in Brazil, we observed a significant predominance of G2P[4] and G2P[NT] strains. G2 RV-As were detected in 148 (74%) out of 199 tested RV-A-positive samples. This genotype was followed by G1, G3 and G9 RV-As, which accounted for 3%, 3% and 11% of the faecal samples, respectively. In this period, mixed and atypical genotypes accounted for 8% of the typed samples. From 2006-2007, G2 RV-As were detected in the states of Rio de Janeiro, Sergipe, Pernambuco, Piauí and Minas Gerais. A recent preliminary analysis indicates the re-emergence of G2 RV-A strains in Northern Brazil, yielding rates of up to 90% of all RV-A isolates as from early 2006 .
Characterization of genotypes in children with RV-A diarrhea has been considered strategic by the World Health Organization (WHO) in order to plan for the introduction of RV-A vaccines (WHO 2002) . They have emphasized the need for previous knowledge of the prevalence of RV-A genotypes in various geographic settings where a RV-A vaccine will be introduced. Moreover, WHO strongly recommends the performance of strain surveillance to monitor circulating RV-A strain diversity and possible strain replacement following the introduction of universal RV-A vaccination (CDC 2007).
The recently developed RV-A vaccines are based on distinct vaccination strategies. The monovalent G1P [8] vaccine Rotarix, which was introduced in Brazil in March 2006, was based on the principle that natural RV-A infections induce significant cross-protection (heterotypic immunity) against severe gastroenteritis regardless of the infecting serotype (Velázquez et al. 1996) . It should be noted that the VP4 epitopes present in genotype P [8] are usually shared by G1, G3, G4 and G9 RV-A strains, which should confer VP4-homotypic protection. Therefore, in regard to the antigenic composition of Rotarix, the only fully heterotypic RV-A genotype is G2P[4], which shares neither VP7 nor VP4 antigens with the vaccine strain. Nonetheless, it is believed that protection against G2P[4] is achieved through cross-reactive epitopes on VP7 and VP4 proteins, together with VP6 epitopes and possibly epitopes on NSP (Grimwood & Kirkwood 2008) .
The nature of the immune response to RV-A infection is not completely understood. Although the immune response to RV-A is not the focus of this paper, we identified multiple studies that aimed to characterize RV-A genotypes responsible for sequential RV-A infections. More specifically, we identified 12 prospective cohort surveys carried out in 10 countries (Fontayne et al. 1978 , Gurwith et al. 1981 , Bishop et al. 1983 , Friedman et al. 1988 , Georges-Courbot et al. 1988 , Linhares et al. 1988 , Reves et al. 1989 , Bernstein et al. 1991 , Bhan et al. 1993 , Ward & Bernstein 1994 , Velázquez et al. 1996 , Moulton et al. 1998 . Altogether, these studies included 2,031 infants, aged 1-24 months, who were followed for periods varying from 12-36 months. Among this population, 306 subjects developed sequential RV-A infections. The first and second RV-A-positive stool samples were typed for only 32 subjects. Twenty-six (81%) of the subjects were reinfected with a genotype that was distinct from that responsible for the first infection. These small numbers illustrate the difficulty in understand the natural history of RV-A sequential infections and, consequently, the immune response against this pathogen.
Uncommon or emergent RV-A genoytpes, which are found mainly in developing countries, trigger discussions about the potential efficacy, in some regions, of the vaccines that were undergoing clinical trials during the early 1990s (Leite et al. 1996 , Gouvea & Santos 1999 . The rationale for the development of the rhesus-human tetravalent reassortant vaccine (RRV-A-TV, Rotashield™), for instance, was that its multivalent composition would target the classical genotypes G1-4. This vaccine was licensed for use in the United States in 1998. The epidemiological importance of G5P[8] RV-A in the 1980s and early 1990s was seen as a potential challenge to the applicability of this vaccine in Brazil. Rotashield™ was withdrawn from the United States immunization schedule due to an identified association with intestinal intussusception (CDC 1999) . Detection of G5 RV-A in many developing countries (Santos & Hoshino 2005a) was probably the first demonstration that non-G1-4 RV-A could be present under endemic or epidemic backgrounds, offering new insights in RV-A vaccination planning and vaccine design. As previously indicated, G5 RV-A was identified in all Brazilian regions, displaying a broad nationwide distribution over at least 14 years. Interestingly, G5 RV-A has disappeared as an endemic/ epidemic strain, as it has been only sporadically detected from 1996 onwards.
The analysis of the 42 RV-A typing surveys published in Brazil since 1988, which include samples collected as early as 1982, allows for outlining of two temporal "scenarios" within the pre-vaccination era, up to 2005. We postulate that such periods might be differentiated by the sharp decline in rates of G5 detection, which coincided with the emergence of G9 RV-As; the latter strains were initially detected in samples collected in 1997 in the state of Rio de Janeiro (Araújo et al. 2001 , Santos et al. 2001 . RV-As belonging to genotype G9 then emerged worldwide in the 1990s. This genotype was subsequently recognized as being highly prevalent in many areas. The study published by Macedo et al. (2007) describes the genotyping of samples collected from 1994-1996 in state of Piauí (Northeastern Brazil). It demonstrates the co-circulation of G5 and G9 RV-A genotypes, but does not specify the year in which the samples were collected. Interestingly, these authors postulate the possibility that G9 was circulating before 1997.
Interestingly, 129 out of 199 RV-A-positive samples collected from 2006-2007 in Brazil were characterized as either G2P [4] or G2P [NT] . These studies were carried out in states of Espírito Santo, Minas Gerais, Pernambuco, Piauí, Rio de Janeiro and Sergipe, suggesting a broad reemergence of this genotype nationwide. Some samples that were characterized as G2P [4] were collected very soon after the introduction of the RV-A vaccine, during the first half of 2006. Of note, many children included in these studies were not eligible for full RV-A vaccination, since they were born before January 2006. We argue that, in those months, with a limited cohort of fully vaccinated infants, G2P[4] reemergence was probably not associated with RV-A vaccination.
The remarkable reemergence of G2P[4] RV-A during the last few years seems to reflect a continental phenomenon. In this context, a recent epidemic of RV-A diarrhea, with a high incidence of the G2P[4] genotype, was reported in Honduras (Ferrera et al. 2007 ). Ongoing surveillance in El Salvador, Guatemala and Honduras demonstrated that G2P [4] was the most prevalent genotype in 2006 (68-81%) (Patel et al. 2008) . Moreover, the G2P[4] genotype was detected to be circulating in Argentina (J Stupka, personal communication) during the last two years. In Paraguay, RV-As characterized as G2P [4] were frequently detected in 2005, following a long period (6 years) of its absence (Amarilla et al. 2007) . It is worth mentioning that these South-American countries bordering Brazil had not yet introduced RV-A vaccination into the public sector and that increased detection of G2P[4] occurred prior to the implementation of Rotarix vaccination in Brazil.
Interestingly, outside of Latin America, the rates of G2P[4] RV-A detection have recently increased in Bangladesh (43% in 2005 Bangladesh (43% in -2006 (Rahman et al. 2007) . Bishop et al. (1991) serotyped 690 RV-A strains collected between 1973-1989 from 943 children admitted with acute diarrhea to a hospital in Melbourne, Australia. They reported interesting findings concerning the seasonal variability of RV-A genotypes: (i) whenever present, G2 RV-As were largely predominant in the epidemiological scenario and this pattern prevailed across three successive seasons; (ii) reemergence of G2 strains tends to occur in 10-year cycles. Extensive and continuous RV-A surveillance studies aiming to assess the pattern of temporal fluctuation in the prevalence rates of RV-A genotypes have not yet been conducted in Brazil. Our current review aims to shed light on this issue by reviewing a representative number of Brazilian RV-A typing studies published from 1988-2007. Herein, we corroborate, to some extent, the findings of Bishop et al. (1991) as we demonstrate a 10-year interval between the decrease in G2 RV-A detection observed after 1996 and its subsequent reemergence in 2006. In light of the above-mentioned findings, some questions emerge regarding the early post-vaccination era. Did RV-A vaccination finish a cycle in RV-A epidemiology in Brazil? If so, to what extent did the monovalent RV-A vaccine contribute to the observed marked shift in genotype distribution? Are the circulating G2 RV-As merely "residual" strains in the context of a remarkable decrease in the rates of RV-A detection in children with gastroenteritis? To that end, will the "residual" strains disappear following a natural fluctuation pattern? Did the continental spread of G2P[4] RV-A affect Brazil because it was a "fertile land" in which a large proportion of children were protected against P[8] strains?
According to Grimwood and Kirkwood (2008) , it is too early to answer such questions. We believe that extensive simultaneous multi-centre surveillance studies with well-designed case-control studies are urgently needed in order to better assess post-vaccination issues such as: (i) the rate of RV-A detection in hospitalized children with gastroenteritis; (ii) the rate of distinct genotypes detection in RV-A-positive children. These strategies are expected to guide and improve future immunization policies.
Future prospects on RV surveillance
Phylogenetic studies of RV-A obtained from different countries have characterized the presence of distinct lineages and sub-lineages of many common genotypes, including G9 (Hoshino et al. 2004 , Araújo et al. 2007b , Phan et al. 2007b (Phan et al. 2007a ) and G4 (Parra et al. 2008) , demonstrating the complex molecular epidemiology of these pathogens. In this context, the immunogenicity and efficacy of RV-A vaccines may be challenged by evolution of the RV-A viral genome. Besides VP4 and VP7 binary classification, sequence analyses have revealed the existence of several distinct NSP4 genotypes: A (KUN), B (Wa), C (AU-1), D (EW) and E (avian-like) (Tavares et al. 2008) . In this context, NSP4 typing of RV-A-positive samples collected in Centralwestern and Southeastern Brazil showed the predominance of genotype B (Araújo et al. 2007b , Tavares et al. 2008 . Recently, Matthijnssens et al. (2008) proposed a new classification system for RV-A, based on the molecular properties of all 11 RV-A gene segments. Phylogenetic analyses suggest that the molecular characteristics of VP1, VP2, VP3, VP6, NSP1, NSP2, NSP3, NSP4 and NSP5 genes result in 4, 5, 6, 11, 14, 5, 7, 11 and 6 genotypes, respectively . These authors propose that this novel genotyping classification system allows for a more systematic approach for investigation of possible genetic linkages among RV-A genome segments. In addition, this system revealed a possible animal origin for the most common human RV-A strains, pointing to the need for simultaneous analysis of animal and human RV-A strains. These findings reemphasize the complexity of RV-A taxonomy, posing new issues to the surveillance programs that should be implemented in the RV-A post-vaccination era, in an attempt to answer remaining questions related to the worldwide distribution of RV-A genotypes as well as the potential for both reassortments and emergence of genotypes. Viral genome detection in environmental samples, including freshwater bodies in many hydrographic networks could contribute to characterizing the RV-A burden in several geographic settings and could be performed simultaneously with hospital-based RV-A surveillance , looking for additional changes in the post-vaccination era.
